(PharmaNewsWire.Com, August 14, 2017 ) Publisher's Medical Devices sector report, "Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB)-Medical Devices Pipeline Assessment, 2017" provides an overview of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by Publisher's team of industry experts.
Scope
- Extensive coverage of the Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry
The report enables you to- - Formulate significant competitor information, analysis, and insights to improve R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of Percutaneous Transluminal Angioplasty (PTA) Peripheral Drug Eluting Balloons (DEB) under development - Develop market-entry and market expansion strategies - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline - In-depth analysis of the product's current stage of development, territory and estimated launch date
Companies Mentioned AnGes MG Inc AngioCure, Inc. C. R. Bard Inc Contego Medical, LLC eucatech AG M.A. Med Alliance SA Medtronic plc Micell Technologies Inc QT Vascular Ltd QualiMed Innovative Medizinprodukte GmbH SiL Vascular Ltd SurModics Inc The Spectranetics Corp Vascular Nanotransfer Technologies Inquire for Report at http://www.reportsweb.com/inquiry&RW0001978928/buying
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
